Clarity Pharmaceuticals was featured in Nature’s MedTech Dealmakers, a publication dedicated to exploring the dealmaking trends of the growing medical technology industry. The article discussed Clarity’s most recent developments and highlighted the benefits of using the Copper-64/Copper-67 pairing in the area of personalised medicine.
Read the full article here:
Or as a PDF
